Buys | $104,852 | 1 | 11 |
Sells | $179,147 | 8 | 89 |
CHOLMONDELEY PAULA H | director | 1 | $104,852 | 0 | $0 | $104,852 |
See Tai Sandi | Chief Development Officer | 0 | $0 | 1 | $6,558 | $-6,558 |
Robertson Jenny | Chief Legal Officer | 0 | $0 | 1 | $9,272 | $-9,272 |
Adler Eric | Chief Medical Officer | 0 | $0 | 1 | $10,410 | $-10,410 |
Townsend Richard Nolan | Chief Executive Officer | 0 | $0 | 5 | $152,908 | $-152,908 |
Lexeo Therapeutics, Inc. operates as a clinical-stage genetic medicine company that focuses on hereditary and acquired diseases. The company develops LX2006, which is an AAVrh10-based gene therapy candidate for the treatment of Friedreich's ataxia (FA) cardiomyopathy; LX2020, an AAVrh10-based gene therapy candidate for the treatment of arrhythmogenic cardiomyopathy; LX2021, a gene therapy candidate for the treatment of DSP cardiomyopathy associated with it; and LX2022, a gene therapy candidate for the treatment of HCM caused by TNNI3 mutations. …
Over the last 12 months, insiders at Lexeo Therapeutics, Inc. Common Stock have bought $104,852 and sold $179,147 worth of Lexeo Therapeutics, Inc. Common Stock stock.
On average, over the past 5 years, insiders at Lexeo Therapeutics, Inc. Common Stock have bought $5.05M and sold $179,147 worth of stock each year.
Highest buying activity among insiders over the last 12 months: CHOLMONDELEY PAULA H (director) — $104,852.
The last purchase of 15,000 shares for transaction amount of $104,852 was made by CHOLMONDELEY PAULA H (director) on 2024‑11‑25.
2025-02-19 | Sale | Townsend Richard Nolan | Chief Executive Officer | 4,326 0.0133% | $4.41 | $19,091 | -33.71% | |
2025-02-19 | Sale | Adler Eric | Chief Medical Officer | 2,359 0.0073% | $4.41 | $10,410 | -33.71% | |
2025-02-19 | Sale | Robertson Jenny | Chief Legal Officer | 2,101 0.0065% | $4.41 | $9,272 | -33.71% | |
2025-02-19 | Sale | See Tai Sandi | Chief Development Officer | 1,486 0.0046% | $4.41 | $6,558 | -33.71% | |
2024-12-10 | Sale | Townsend Richard Nolan | Chief Executive Officer | 2,500 0.0076% | $8.20 | $20,491 | -35.17% | |
2024-11-25 | CHOLMONDELEY PAULA H | director | 15,000 0.0385% | $6.99 | $104,852 | -22.41% | ||
2024-11-11 | Sale | Townsend Richard Nolan | Chief Executive Officer | 2,500 0.0072% | $7.82 | $19,557 | -26.16% | |
2024-10-10 | Sale | Townsend Richard Nolan | Chief Executive Officer | 5,000 0.0149% | $8.10 | $40,496 | -19.72% | |
2024-09-10 | Sale | Townsend Richard Nolan | Chief Executive Officer | 5,000 0.0196% | $10.65 | $53,274 | -32.75% | |
2023-11-07 | Longitude Capital Partners IV, LLC | 10 percent owner | 454,545 1.8373% | $11.00 | $5M | +25.53% | ||
2023-11-07 | Omega Fund VI, L.P. | 10 percent owner | 454,545 1.8373% | $11.00 | $5M | +25.53% |
CHOLMONDELEY PAULA H | director | 30627 0.0926% | $94,024.89 | 1 | 0 | |
Longitude Capital Partners IV, LLC | 10 percent owner | 2567100 7.7636% | $7.88M | 1 | 0 | +25.53% |
Omega Fund VI, L.P. | 10 percent owner | 2157623 6.5252% | $6.62M | 1 | 0 | +25.53% |
$12,784,645 | 193 | 20.49% | $111.89M | |
$22,597,521 | 91 | 4.59% | $104.68M | |
$47,282,828 | 47 | -17.38% | $96.94M | |
$7,147,964 | 34 | 24.78% | $96.35M | |
$36,079,815 | 31 | 43.23% | $103.59M |
Increased Positions | 59 | +103.51% | 4M | +12.79% |
Decreased Positions | 19 | -33.33% | 4M | -13.53% |
New Positions | 29 | New | 1M | New |
Sold Out Positions | 9 | Sold Out | 976,915 | Sold Out |
Total Postitions | 97 | +70.18% | 29M | -0.74% |
Janus Henderson Group Plc | $12,410.00 | 13.15% | 4.34M | +576,059 | +15.31% | 2024-12-31 |
Citadel Advisors Llc | $7,789.00 | 8.25% | 2.72M | 0 | 0% | 2024-12-31 |
Adage Capital Partners Gp, L.L.C. | $6,319.00 | 6.7% | 2.21M | -388,121 | -14.94% | 2024-12-31 |
D1 Capital Partners L.P. | $6,303.00 | 6.68% | 2.2M | -302,707 | -12.08% | 2024-12-31 |
Blackrock, Inc. | $5,211.00 | 5.52% | 1.82M | +191,679 | +11.76% | 2024-12-31 |
Eventide Asset Management, Llc | $3,532.00 | 3.74% | 1.23M | -621,152 | -33.47% | 2024-12-31 |
Vestal Point Capital, Lp | $3,432.00 | 3.64% | 1.2M | +350,000 | +41.18% | 2024-12-31 |
Omega Fund Management, Llc | $3,388.00 | 3.59% | 1.18M | -1M | -49.72% | 2024-12-31 |
Blackstone Inc. | $3,314.00 | 3.51% | 1.16M | 0 | 0% | 2024-12-31 |
Novo Holdings A/S | $3,211.00 | 3.4% | 1.12M | 0 | 0% | 2024-12-31 |